November 30, 2023
A Blue Cross affiliate has once again lodged a proposed class action against Takeda Pharmaceuticals over an alleged conspiracy to keep generic versions of the drug Amitiza off the market, filing a tweaked version of its suit just weeks after a Massachusetts federal judge threw out its initial attempt.